Pfizer reported 18% second-quarter revenue growth, excluding currency impacts, and raised its full-year revenue forecast midpoint by $500 million. Those gains favor the company, though full results are still due later this week.
The higher expected revenue total suggests Pfizer sees stronger sales continuing through the year. The full quarterly report is still due later this week, but the reported sales growth and raised forecast point in a favorable direction.
Follow Pfizer Inc. (PFE) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for PFE